Obesity, oxidative stress and breast cancer risk

Journal of Cancer Science and Therapy

Volumn 5, Issue 12, 2013, Pages

  Hakkak, Reza ^a,b,c   Korourian, Soheila ^b   Melnyk, Stepan ^b,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c ARKANSAS CHILDREN S HOSPITAL RESEARCH INSTITUTE   (United States)

Author keywords

Breast cancer; Obesity; Oxidative stress

Indexed keywords

CYTOKERATIN 8; ESTROGEN RECEPTOR; PRASTERONE; REACTIVE OXYGEN METABOLITE;

BODY MASS; BREAST CANCER; CANCER MORTALITY; CANCER RISK; DIABETES MELLITUS; EDITORIAL; HUMAN; MITOCHONDRIAL DNA DISORDER; NONHUMAN; OBESITY; OXIDATIVE STRESS; POSTMENOPAUSE;

EID: 84893147930     PISSN: None     EISSN: 19485956     Source Type: Journal    
DOI: 10.4172/1948-5956.1000e129     Document Type: Editorial

References (25)

1. Calle E, Rodriguez C, Walker-Thurmond K, Thun M (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348: 1625-1638.
2. American Cancer Society (2013) Cancer Facts & Figures 2013.
3. Centers for Disease Control and Prevention (2012) Overweight and Obesity: Adult Obesity Facts.
4. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, et al. (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289: 76-79.
5. Conroy SM, Maskarinec G, Wilkens LR, White KK, Henderson BE, et al. (2011) Obesity and breast cancer survival in ethnically diverse postmenopausal women: the Multiethnic Cohort Study. Breast Cancer Res Treat 129: 565-574.
6. Loi S, Milne RL, Friedlander ML, McCredie MR, Giles GG, et al. (2005) Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 14: 1686-1691.
7. Niraula S, Ocana A, Ennis M, Goodwin PJ (2012) Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis. Breast Cancer Res Treat 134: 769-781.
8. Howell JS (1961) Intranasal administration of 9,10-dimethyl-1, 2-benzanthracene to rats: the development of breast and lung tumours. Br J Cancer 15: 263-269.
9. Huggins C, Grand LC, Brillantes FP (1961) Mammary cancer induced by a single feeding of polymucular hydrocarbons, and its suppression. Nature 189: 204-207.
10. Hakkak R, Holley AW, Macleod SL, Simpson PM, Fuchs GJ, et al. (2005) Obesity promotes 7,12-dimethylbenz(a)anthracene-induced mammary tumor development in female zucker rats. Breast Cancer Res 7: R627-633.
11. Hakkak R, MacLeod S, Shaaf S, Holley A, Simpson P, et al. (2007) Obesity increases the incidence of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in an ovariectomized Zucker rat model. Int J Oncol 30: 557-563.
12. Simile M, Pascale RM, De Miglio MR, Nufris A, Daino L, et al. (1995) Inhibition by dehydroepiandrosterone of growth and progression of persistent liver nodules in experimental rat liver carcinogenesis. Int J Cancer 62: 210-215.
13. Hakkak R, Shaaf S, Jo CH, MacLeod S, Korourian S (2010) Dehydroepiandrosterone intake protects against 7,12-dimethylbenz(a) anthracene-induced mammary tumor development in the obese Zucker rat model. Oncol Rep 24: 357-362.
14. Crujeiras AB, Díaz-Lagares A, Carreira MC, Amil M, Casanueva FF (2013) Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer. Free Radic Res 47: 243-256.
15. Traverso N, Ricciarelli R, Nitti M, Marengo B, Furfaro AL, et al. (2013) Role of glutathione in cancer progression and chemoresistance. Oxid Med Cell Longev 2013: 972913.
16. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160: 1-40.
17. Sosa V, Moliné T, Somoza R, Paciucci R, Kondoh H, et al. (2013) Oxidative stress and cancer: an overview. Ageing Res Rev 12: 376-390.
18. Ziech D, Franco R, Georgakilas AG, Georgakila S, Malamou-Mitsi V, et al. (2010) The role of reactive oxygen species and oxidative stress in environmental carcinogenesis and biomarker development. Chem Biol Interact 188: 334-339.
19. Vera-Ramirez L, Sanchez-Rovira P, Ramirez-Tortosa MC, Ramirez-Tortosa CL, Granados-Principal S, et al. (2011) Free radicals in breast carcinogenesis, breast cancer progression and cancer stem cells. Biological bases to develop oxidative-based therapies. Crit Rev Oncol Hematol 80: 347-368.
20. Kang DH (2002) Oxidative stress, DNA damage, and breast cancer. AACN Clin Issues 13: 540-549.
21. Rohan TE, Wong LJ, Wang T, Haines J, Kabat GC (2010) Do alterations in mitochondrial DNA play a role in breast carcinogenesis? J Oncol 2010: 604304.
22. Jezierska-Drutel A, Rosenzweig SA, Neumann CA (2013) Role of oxidative stress and the microenvironment in breast cancer development and progression. Adv Cancer Res 119: 107-125.
23. Benz CC, Atsriku C, Yau C, Britton D, Schilling B, et al. (2006) Novel pathways associated with quinone-induced stress in breast cancer cells. Drug Metab Rev 38: 601-613.
24. Mukherjee S, Koner BC, Ray S, Ray A (2006) Environmental contaminants in pathogenesis of breast cancer. Indian J Exp Biol 44: 597-617.
25. Calle EE, Thun MJ (2004) Obesity and cancer. Oncogene 23: 6365-6378.